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Abstract
Herpesvirus infection of placenta may be harmful in pregnancy leading to disorders in fetal growth, premature delivery,
miscarriage, or major congenital abnormalities. Although a correlation between human herpesvirus 8 (HHV-8) infection and
abortion or low birth weight in children has been suggested, and rare cases of in utero or perinatal HHV-8 transmission have
been documented, no direct evidence of HHV-8 infection of placenta has yet been reported. The aim of this study was to
evaluate the in vitro and in vivo susceptibility of placental cells to HHV-8 infection. Short-term infection assays were
performed on placental chorionic villi isolated from term placentae. Qualitative and quantitative HHV-8 detection were
performed by PCR and real-time PCR, and HHV-8 proteins were analyzed by immunohistochemistry. Term placenta samples
from HHV-8-seropositive women were analyzed for the presence of HHV-8 DNA and antigens. In vitro infected histocultures
showed increasing amounts of HHV-8 DNA in tissues and supernatants; cyto- and syncitiotrophoblasts, as well as
endothelial cells, expressed latent and lytic viral antigens. Increased apoptotic phenomena were visualized by the terminal
deoxynucleotidyl transferase-mediated deoxyuridine nick end-labeling method in infected histocultures. Ex vivo, HHV-8
DNA and a latent viral antigen were detected in placenta samples from HHV-8-seropositive women. These findings
demonstrate that HHV-8, like other human herpesviruses, may infect placental cells in vitro and in vivo, thus providing
evidence that this phenomenon might influence vertical transmission and pregnancy outcome in HHV-8-infected women.
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Introduction
Human placenta is susceptible to herpesvirus infection, and
trophoblast infection may play a relevant role in placental
dysfunction, leading to pregnancy complications [1–3]. Intrauter-
ine herpesvirus infection may be associated with pathological
conditions, such as disturbances in fetal growth, premature
delivery, miscarriage, or major congenital abnormalities. Herpes
simplex virus type 1 (HSV-1), Varicella-Zoster virus (VZV), and
Cytomegalovirus (CMV) are well-established causes of in utero or
intrapartum infection [2]. HSV-1 infection may be associated with
fetal demise or neonatal herpes; HSV-1 infection of extravillous
cytotrophoblasts may cause abnormal placental attachment to the
uterine wall at an early gestational stage, leading to miscarriage
[4]. Intrauterine or intrapartum VZV infection is linked to
congenital or neonatal varicella. VZV DNA was detected in both
maternal and fetal compartments of placenta [5], and trophoblasts
were found to express a latency viral program [6]. Congenital
CMV infection is the most common transplacentary transmitted
viral infection, and it may cause multiorgan affection. Cytotro-
phoblasts, but not syncytiotrophoblasts, were shown to be
permissive to CMV replication in vitro [7]. As far as the other
human herpesviruses are concerned, transplacental transmission of
Epstein-Barr virus (EBV), HHV-6, or HHV-7 appear to be rare,
and pathological conditions possibly associated with these events
are still unknown, although HHV-6 and EBV were shown to infect
syncytiotrophoblast cells in vitro [4,8–10].
To date, little data is available concerning the congenital
transmission of HHV-8, the most recently discovered member of
Herpesviridae. HHV-8 infection is linked to the development of
Kaposi’s sarcoma, primary effusion lymphoma and the plasma-
blastic variant of multicentric Castleman’s disease [11–13]. A high
prevalence of HHV-8 infection has been demonstrated in children
living in African and Mediterranean countries, where HHV-8 is
endemic [14,15]. Modalities for HHV-8 spread in children have
not been fully elucidated. Saliva, in which infectious virus can be
PLoS ONE | www.plosone.org 1 December 2008 | Volume 3 | Issue 12 | e4073frequently detected [16,17], was shown to play a major role in
HHV-8 infection of children [18,19]. However, mother-to-child
transmission, not involving saliva exchanges, may also occur. In
fact, rare cases of in utero and perinatal HHV-8 transmission were
documented by the detection of HHV-8 DNA in the newborn’s
blood at birth, both in endemic and sub-endemic areas [20–22].
HHV-8 was also shown to reactivate during pregnancy among
HIV-1-co-infected women, and reactivation might play a role in
vertical transmission [22]. Furthermore, correlations between
HHV-8 infection of the mother and intrauterine growth restriction
[23] as well as between anti-HHV-8 antibody titers and abortion
[24] have been reported.
In spite of these intriguing and undefined aspects, contrarily to
other human herpesviruses, there is still a lack of information
about the in vitro and in vivo tropism of HHV-8 for placental cells.
Studies addressing this topic are necessary for clarifying the
possible relationships between HHV-8 and pregnancy. Here we
investigated the susceptibility of human placental cells to in vitro
HHV-8 infection using a placental histoculture system and found
that HHV-8 may productively infect placental trophoblasts and
endothelial cells. Moreover, we demonstrated the presence of viral
DNA and proteins in placenta tissues obtained from HHV-8-
seropositive women, indicating that HHV-8 infection of placenta
may also occur, although rarely, in vivo.
Results
Placenta cells express HHV-8 receptors
The expression of some of the molecules required for viral
attachment and entry, heparan sulfate (HS) and a3b1 integrin, was
tested on placental sections. We observed that both endothelial cells
and cyto/syncytiotrophoblasts expressed the a3b1 integrin
(Figure 1A), while HS was detected only in endothelial cells
(Figure 1B).
Placenta histocultures support HHV-8 lytic replication
To evaluate the susceptibility of placental histocultures to HHV-
8 infection, we performed infection experiments using virus stocks
at a final concentration of 7.5–20610
6 genome equivalents (GE)/
ml. The presence and load of viral DNA were evaluated 48 h,
72 h and 7 days after exposure to the viral or mock supernatants.
HHV-8 sequences were detected by PCR in the DNA extracted
from all fragments exposed to HHV-8 (data not shown). Figure 2
shows the median values of HHV-8 load measured in the placental
histocultures and culture supernatants at 48 h, 72 h and 7 days
post-infection (PI) in 3 independent experiments. The GEs
measured in the placental fragments ranged from 65 to 750/10
5
cells 48 h after infection. HHV-8 load was found to increase at
Figure 1. a3b1 integrin and heparan sulfate are expressed in
placental histocultures. (A) Intense immunoreactivity (brown
colour) of a3b1 integrin was observed in endothelial cells (white arrow)
and syncytiotrophoblasts (blue arrow). (B) Heparan sulfate immunore-
activity was observed only in endothelial cells (white arrow). Original
magnifications, 640.
doi:10.1371/journal.pone.0004073.g001
Figure 2. HHV-8 infection of placental histocultures. HHV-8 load was measured 48 h, 72 h and 7 days after infection in the placental tissues
(histograms) and in culture supernatants (dots). Increasing viral loads were detected in tissue fragments and in culture supernatants of infected
histocultures, suggesting a productive viral infection. Results are reported as HHV-8 genome equivalents (GE) per 100,000 cells or per ml of
supernatant, and are plotted as means6standard errors of three independent experiments performed in duplicate.
doi:10.1371/journal.pone.0004073.g002
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ongoing productive infection and spreading of the virus to
uninfected cells. Virus production in culture supernatants showed
an increase generally at 7 days PI (Figure 2), although some
cultures showed the opposite trend with a replication peak at 72 h
PI in culture supernatants. The observed increment in viral
particles released in the culture supernatants ruled out the
possibility that detection was due to residual viral input. The
BBF cell line, previously found to support HHV-8 replication [17],
was exposed to filtered culture supernatants obtained from
microexplants 72 h PI; an open reading frame (ORF) 26-specific
PCR product was amplified from cellular DNA 5–7 days PI, and
in parallel viral progeny was detected in BBF supernatants (data
not shown), indicating that infectious viral particles were released
from infected microexplants.
Altogether, these data indicate that placental histocultures were
found to be permissive to HHV-8 infection, support the lytic
replication program of the virus and release infectious viral
particles.
HHV-8 antigens are expressed in trophoblasts and
endothelial cells
To analyze the expression profile of HHV-8 in placental
histocultures, the presence of viral proteins was examined by
immunohistochemistry with a monoclonal antibody that detects
the latency-associated nuclear antigen (LANA) (Figure 3) and a
polyclonal antibody that detects a viral lytic protein encoded by
ORF K2 (viral interleukin 6, vIL-6) (Figure 4). Tissue sections
were analyzed at 48 h, 72 h and 7 days PI. A fine granular nuclear
pattern typical of the LANA antigen was observed in both cyto-
and syncytiotrophoblasts, as well as in endothelial cells, as shown
in Figure 3B, in all HHV-8-exposed sections collected at the
three time points. Concerning vIL-6 expression, strong cytoplas-
matic staining was observed in syncytiotrophoblasts as well as in
endothelial cells (Figure 4).
To further confirm those cell types permissive to HHV-8
infection in placental histocultures, double immunohistochemical
staining was performed using monoclonal antibodies against
cytokeratin 7 as a marker for cyto- and syncytiotrophoblasts or
against CD31 for endothelial cells, in combination with the anti-
LANA antibody. Endothelial (Figure 5A) and trophoblasts cells
(Figure 5B) expressed the LANA antigen, thus confirming that
both cell types are permissive to HHV-8 infection. Double
immunohistochemical staining using CD68 as marker for
monocytes and anti-LANA antibody resulted negative (data not
shown).
Apoptosis is relevant in in vitro infected placental
fragments
Apoptotic nuclei were qualitatively analyzed using the terminal
deoxynucleotidyl transferase-mediated dUTP nick end-labeling
(TUNEL) assay at 48 h and 72 h PI and visualized by confocal
microscopy. Apoptotic nuclei were observed in HHV-8-infected
placental histocultures, as shown in Figure 6 (panels A and B).
Immunohistochemical analysis confirmed these findings
(Figure 7A). A small number of apoptotic cells were also observed
in mock-infected histocultures (Figure 6, panels C and D;
Figure 7B); however, the apoptotic phenomenon was more
evident in HHV-8-infected placentae, thus suggesting important
damage of the placenta tissue by HHV-8.
Figure 4. Immunohistochemical detection of the viral interleu-
kin-6 (vIL-6) in placental histocultures. (A) Immunohistochemical
staining showed a strongly positive cytoplasmic staining in both
endothelial cells (white arrow) and syncytiotrophoblasts (blue arrow) in
HHV-8-infected placental histocultures. (B) Mock-infected placental
histocultures. Original magnifications, 6100 (A), 663 (B).
doi:10.1371/journal.pone.0004073.g004
Figure 3. Immunohistochemical detection of the HHV-8 LANA
protein in placental histocultures. Specific reactivity was visualized
with immunoperoxidase staining using anti-LANA-1 monoclonal
antibody with a DAB developer (brown colour) and haematoxylin
counterstaining. (A) HHV-8-infected CRO-AP/3 cells showed a strongly
positive nuclear immunostaining. (B) HHV-8-infected placental histo-
cultures showed positive immunostaining in cytotrophoblasts (yellow
arrow), syncytiotrophoblasts (blue arrow) and endothelial cells (white
arrow). (C) Mock-infected placental histocultures. Original magnifica-
tions, 6100.
doi:10.1371/journal.pone.0004073.g003
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infected women
To assess whether or not our in vitro findings could be confirmed
in vivo, we searched for HHV-8 DNA in placenta samples from 60
HHV-8-seropositive women (30 from Italy and 30 from
Cameroon). PCR analyses revealed the presence of HHV-8
DNA sequences in 3 placenta samples from Cameroonian women,
whereas samples from Italian women were repeatedly negative.
Two of these three samples were available for immunohistochem-
ical analyses for latent (LANA) and lytic (vIL-6) viral proteins. In
both samples, a small number of cytotrophoblasts (Figure 8A) and
endothelial cells (Figure 8B) positive for LANA could be detected.
Infection of these cell types was confirmed by double immuno-
staining for cytokeratin 7 and CD31 (data not shown). vIL-6
expression could not be detected in the two examined placental
samples.
These data provide evidence that HHV-8 DNA and latent
proteins can be found in term placenta tissues from HHV-8-
infected women, indicating that HHV-8 can infect, albeit rarely,
placenta cells in vivo.
Discussion
The aim of this study was to gain insight into the possible
contribution of placenta HHV-8 infection to mother-to-child
transmission of this human herpesvirus. To this end, we used a
placental histoculture system to evaluate the permissiveness of
placental tissue to HHV-8 infection, and to characterize the
infection by determining the susceptible cell types. Moreover, we
examined the presence of HHV-8 DNA and/or antigens in term
placentae from HHV-8-seropositive women.
Analysis of the expression of some of the molecules required for
HHV-8 attachment and entry [25,26] revealed that both heparin
sulfate and a3b1 integrin are expressed in endothelial cells inside
the villous stroma (Figure 1). Interestingly, a3b1 integrin was
Figure 6. Immunofluorescence for detection of apoptotic cells. Immunofluorescence for qualitative detection of apoptotic cells in placental
histocultures was performed by using the TUNEL assay. Apoptotic nuclei were more frequently evidenced in HHV-8-infected microexplants 48 h (A)
and 72 h (B) after infection than in mock-infected microexplants 48 h (C) and 72 h (D) after mock infection. Original magnifications, 640.
doi:10.1371/journal.pone.0004073.g006
Figure 5. Double immunohistochemical staining for HHV-8
LANA antigens, CD31 and cytokeratin-7 in infected histocul-
tures. (A) Double staining performed using peroxidase for the viral
LANA protein (brown) and alkaline phosphatase for the vascular-
associated CD31 marker (blue) showed coexpression of these proteins
in endothelial cells (white arrow). (B) Double staining using peroxidase
for LANA (brown) and alkaline phosphatase for cytokeratin-7 (blue)
showed coexpression of these proteins in syncytiotrophoblasts (blue
arrow). Original magnifications, 6100.
doi:10.1371/journal.pone.0004073.g005
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HS was not observed, suggesting that HHV-8 might use
alternative molecules for initial attachment to these cells. Exposure
of placenta fragments to HHV-8 stocks resulted in a productive
infection. In fact, increasing amounts of HHV-8 DNA were
detected in placental fragments and in culture supernatants
(Figure 2). Moreover, infected histocultures released infectious
virus particles (data not shown) suggesting that placental cells can
support the entire lytic replication cycle. Immunohistochemistry
studies confirmed these findings and characterized the cell types
permissive to HHV-8 infection (Figures 3–5). In fact, cyto- and
syncytiotrophoblasts as well as endothelial cells were found to
express the LANA antigen and the lytic vIL-6 protein.
Villous trophoblast apoptosis is a normal event during placental
development [27], and it is increased in placentas associated with
intrauterine growth restriction [28]. Apoptotic nuclei in infected
histocultures were detected more frequently than in mock-infected
microexplants (Figures 6 and 7). It is thus conceivable that
placental infection in vivo might lead to disturbances in placental
metabolic activity that could in turn cause placental damage and
favour obstetrical complications and/or affect fetal growth. Our
preliminary data are qualitative and limited to an in vitro model,
and further in-depth studies will be needed to fully clarify the
pathogenetic mechanisms involved in vertical transmission and/or
pregnancy interference in HHV-8-infected women.
In vitro placenta infection data were supported by the analyses of
ex vivo placenta samples from HHV-8-seropositive women. PCR
analyses showed that 3 of 60 placenta samples harboured viral
DNA and immunohistochemical studies performed on two of
them revealed the presence of LANA expression in a few
endothelial and trophoblast cells (Figure 8). It is important to
note that placenta samples from all tested Italian HHV-8-
seropositive women were negative for HHV-8-specific sequences.
Similarly, in a previous study, PCR analyses of three placenta
samples from Italian HIV-1/HHV-8-infected women failed to
detect HHV-8 sequences [22]. In the present study, placenta
samples with detectable HHV-8 DNA and antigens were obtained
from a highly endemic population from Central Africa [29,30], in
which a high HHV-8 seroprevalence was observed in pregnant
women and prostitutes [31]. Our findings may therefore reflect a
higher viral load in this African population due to several
concomitant factors. Indeed, augmented viral burden may be
linked to pregnancy-related increased viral replication [22], co-
morbid conditions and socio-demographic characteristics, such as
low socio-economic status [32–34], that may thus increase the risk
for transplacental transmission of HHV-8. In sub-endemic
countries, such as Italy, this transmission route might be restricted
to populations at high risk for HHV-8 infection, such as HIV-1-co-
infected women [22]. Further studies will thus be necessary to
examine risk factors for HHV-8 transplacental transmission.
To our knowledge, thisisthe first report that describes in vitro and in
vivo HHV-8 infection of placental cells. Other human herpesviruses
have been shown to infect placental cells, and this event may lead to
transmission to the fetus and/or adverse pregnancy outcome.
Concerning HHV-8, scanty data is available on the significance of
HHV-8 infection in pregnancy. Rare cases of in utero and perinatal
transmission have been demonstrated in endemic areas [20,21].
Moreover, we have previously shown that pregnancy may induce
HHV-8 reactivation in HIV-1-infected women living in sub-endemic
areas [22]. The increased viral load, observed in the peripheral blood
and in the genital compartment, might in turn affect the risk for in
utero or perinataltransmissionof HHV-8, as acase of primary HHV-8
infection was found in a child born to a mother with HHV-8
reactivation [22]. Furthermore, HHV-8 infection might also affect
Figure 7. Immunohistochemistry for detection of apoptotic
cells. Apoptotic nuclei, visualized by immunohistochemistry, were
more frequently detected in HHV-8-infected placental histocultures (A)
than in mock-infected microexplants (B) 48 h post-infection. Original
magnifications, 640.
doi:10.1371/journal.pone.0004073.g007 Figure 8. Immunohistochemical detection of the HHV-8 LANA
protein in ex vivo placenta tissues. Specific reactivity was visualized
with immunoperoxidase staining using anti-LANA monoclonal antibody
with a DAB developer (brown colour) and haematoxylin counterstain-
ing. A term placenta tissue obtained from an HHV-8-seropositive
woman, and found to be HHV-8-DNA positive by PCR, showed positive
nuclear immunostaining in rare cytotrophoblasts (A) (yellow arrow) and
endothelial cells (B) (white arrow). A term placenta tissue from an HHV-
8-seropositive woman, found to be HHV-8-DNA negative, showed no
specific immunostaining (C). Original magnifications,663 (A),6100 (B),
620 (C).
doi:10.1371/journal.pone.0004073.g008
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weight and HHV-8 infection was demonstrated in 407 women from
Senegal [23]. Sarmati and coworkers found a higher abortion rate in
HHV-8-seropositive women, and demonstrated an association
between high antibody titers and abortion [24]. In contrast, we did
not previously observe a correlation between intra-uterine growth
restriction and HHV-8reactivation in a group of 15 HIV-1/HHV-8-
positive pregnant women [22]. In the present study we could not
address this aspect, as only term pregnancies were included, thus
excluding premature deliveries and abortions from analysis. Another
limit of this study is that information about HHV-8 infection in
newborns born to mothers with infected placenta tissues was not
available.
In conclusion, we here demonstrated for the first time that
trophoblasts as well as placental endothelial cells can be infected in
vitro and in vivo, thus providing evidence that transplacental
transmission may, albeit rarely, occur, and that vertical transmis-
sion may play a role in HHV-8 spread. Further ongoing in vitro and
ex vivo studies will better clarify the influence of HHV-8 infection
on pregnancy and the pathogenetic mechanisms involved in
mother-to-child transmission.
Materials and Methods
Placental histocultures
Term placentae were obtained after elective cesarean section and
were processed within one hour after collection as described
elsewhere [35]. Briefly, placental chorionic villi were isolated,
minced into 2–3 mm blocks, and washed extensively with RPMI
1640 supplemented with 10% heat-inactivated fetal bovine serum
(FCS), 1% penicillin-streptomycin and 1% L-glutamine (washing
medium). After exposure to virus stocks, all fragments were washed
extensively with washing medium. During washes, collagen sponges
(Condress collagene, Abiogen Pharma SpA, Italy) were placed
individually into wells of 6-well plates with3 ml/well of RPMI 1640
supplemented with 15% FCS, 1% penicillin-streptomycin, 0,1%
gentamycin, 1% amphotericin B, 1% L-glutamine, 1% non-
essential amino acids, and 1% sodium pyruvate (culture medium).
The fragments were then placed on top of the collagen sponges (9
fragments per sponge per well) at the interface between the medium
and the air. Histocultures were maintained at 37uC in a humidified
incubator with 5% CO2 for 7 days.
HHV-8 infection assay
Virus stocks were prepared using the HHV-8 infected CRO-AP/
3 cell line [36] treated with 3 mM n-butyrate for 48 h or with
0.6 mM valproate (2-propylpentanoic acid) for 5 days to induce the
HHV-8 lytic cycle. Supernatants were processed and concentrated
as previously described [17]. Placental histocultures (18–20
fragments) were exposed to virus stocks containing 15–40610
6
genome equivalents in a final volume of 2 ml of washing medium,
and in parallel, to washing medium alone (mock infection). After
12 h, placental fragments were extensively washed and placed on
top of collagen sponge gels in culture medium. Supernatant (1 ml)
and placental fragments were collected after 48 h, 72 h and 7 days
from exposure to the virus or mock inocula. Collected supernatants
were replaced with the same amount of fresh culture medium; half
of the culture medium was replaced with fresh complete medium
after 5 days. Supernatants werecentrifuged at 2.800 g for 30 min to
eliminate cell debris, filtered through a 0.45 mm-pore-size filter
(Millipore, MA, USA), and stored at 280uC. Virus- and mock-
exposed fragments were washed twice in RPMI 1640 and stored at
280uC or directly fixed in formalin. Each experiment was set up in
duplicate and performed three times. The infectivity of each virus
stock and of the virus released from infected histocultures was
assessed in short-term infection assays performed using the BJAB-
derived BBF cell line, previously shown to support HHV-8 latent
and lytic replication, as reported [17].
Term placentae from HHV-8-seropositive women
Study participants were part of a cohort study of 200 HIV-1-
seronegative pregnant women. One hundred and fifty were Italian
women referring for delivery to the Obstetric and Gynaecological
Clinic at the University of Foggia, Italy, and 50 were Cameroonian
women referring for delivery to the Centre d’Animation Sociale et
Sanitaire (CASS), Nkoldongo Yaounde, Cameroon. This study was
reviewed and approved by the Cameroon National Ethical
Committee and by the Institutional Review Board, University of
Foggia Medical School (Italy). Written informed consent was
obtained from each woman, who provided a serum sample and a
placenta sample at delivery. About 10 to 15 mm
3 pieces of placental
tissue were randomly collected from the maternal side and extensively
washed in phosphate buffered saline (PBS) containing 2% penicillin/
streptomycin. Italian placenta samples were either immediately
frozen at 280uC and fixed in 10% formalin. Instead, the placental
fragments from Cameroonian women were embedded in Tissue-Tek
ornithine carbamyl transferase compound (OCT) (Sakura Finetek,
The Netherlands) and stored at 280uC. All serum samples, stored at
220uC until use, were analyzed for the presence of anti-HHV-8
antibodies using an indirect immunofluorescence assay (HHV-8 IgG
Antibody IFA Kit, Advanced Biotechnologies Inc’s, ABI, MD, USA).
A total of 60 women (30 from Italy and 30 from Cameroon) were
found to be HHV-8-seroreactive. Placenta samples from these
women were analyzed for the presence of HHV-8 sequences by PCR
and those found to be positive were subsequently examined for
HHV-8 antigens by immunohistochemistry.
PCR and quantitative HHV-8 load analyses
DNA was extracted from virus-exposed or mock-infected placental
fragments and from ex vivo placenta samples from 60 HHV-8-
seropositive women. DNA samples were analysed by PCR to assess
the presence of HHV-8 DNA ORF26-specific primers as previously
described [37]. DNA was also extracted from an aliquot of
ultracentrifuged supernatants from induced CRO-AP/3 cells to
measure the amount of GE, from 200 ml of supernatants from virus-
exposed and mock-treated placental cultures to quantify virus release,
and from 200 ul of supernatants from BBF cells infected with CRO-
AP/3-derived viral stocks or with supernatants from infected
placental histocultures, as described previously [17]. Quantitative
detection of HHV-8 was performed by real-time PCR [17].
Antibodies
Term placenta tissues were analyzed for the expression of
heparan sulfate (HS) using a mouse anti-HSPG monoclonal
antibody (mAb) and for a3b1 integrin using a mouse anti-VLA-3
mAb (Chemicon International, CA, USA) to identify some of the
molecules involved in virus entry. To characterize placental cell
types, we used a mouse anti-cytokeratin 7 mAb to detect
trophoblasts, a mouse anti-CD31 mAb to identify endothelial
cells, and a mouse anti-CD-68 mAb to detect macrophages
(DakoCytomation, Glostrup, Denmark). A rat mAb to the LANA
antigen encoded by ORF 73 and a rabbit polyclonal antibody to
the vIL-6 (ABI) were used to detect HHV-8-specific proteins.
Histochemistry and immunohistochemistry
Placenta specimens were collected after 48 h, 72 h and 7 days
from exposure to the virus stocks or mock inocula, fixed in 10%
HHV-8 Infects Placental Cells
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ethanol, and embedded in paraffin. Sections were cut (4-mm thick)
from histoculture samples and from OCT-embedded ex vivo
placental samples, and prepared for appropriate staining.
Hematoxylin–eosin staining was used for histological diagnosis.
For immunohistochemical staining, the sections were mounted on
poly-L-lysine-coated slides, deparaffined, incubated in xylene for
20 minutes, followed by washing with decreasing volumes of
ethanol, and then washed with distilled water and with PBS for
10 minutes. The sections were then treated with a proteolytic
enzyme at room temperature for 15 minutes and washed with
PBS. For detection of the LANA antigen, the sections were not
treated with a proteolytic enzyme but were heated in a microwave
oven for 15 minutes at 600 W with a citrate buffer (0.01 mol/L,
pH 6). All sections were incubated in a solution of 3% H2O2 for
15 min to inhibit endogenous peroxidase activity, and incubated
overnight at 4uC with the primary antibody. The sections were
washed twice with PBS, incubated with biotinylated IgG for
15 minutes, washed twice with PBS, and incubated with
streptavidin-peroxidase conjugate (LSAB2 System-HRP, Dako-
Cytomation). After washing with PBS, the sections were incubated
with diaminobenzidine (DAB) and/or 3-amino-9-ethylcarbazole
(AEC) substrate to stain immunolabelling and then with Mayer’s
hematoxylin. Sections were covered with mounting medium and
analysed with a light microscope. Negative controls (i.e. mock-
infected histocultures) were processed in an identical manner. To
examine non-specific reactivity, all samples were analyzed by
either omitting the primary antibody or by replacing the primary
antibody with an isotype-matching antibody.
The monoclonal antibody anti-a3b1 integrin was nonreactive on
paraffin sections and required frozen materials. Therefore, the
placenta tissue was frozen immediately in liquid nitrogen,
embedded in OCT and stored at 280uC until use. For
immunohistochemistry, sections were cut, air dried and fixed in
acetone for 10 minutes. The immunohistochemical staining was
done as described above.
Double immunohistochemical staining
Immunohistochemical procedures were performed on selected
samples with double staining to evaluate the cell types infected by
HHV-8. Briefly, after incubation with the first antibody and the
DAB colour reaction, the sections were incubated with a second
mAb (anti-cytokeratin 7, anti-CD31 or anti-CD68) followed by the
alkaline phosphate method with blue detection system or AEC
system (Vector Laboratories Inc, CA, USA). Double-stained cells
were characterized if both brown/red or blue colours could be
discerned within one cell.
Apoptosis detection in placental histocultures
Apoptosis was analyzed in placenta histocultures by using a
commercially available apoptosis detection kit (In Situ Cell Death
Detection Kit, Roche Molecular Biochemicals, Mannheim,
Germany). The system end-labels the fragmented DNA of
apoptotic cells by using the modified TUNEL assay that allows
for the incorporation of biotinylated nucleotides at the 39-OH
DNA ends. The assay was performed according to the
manufacturer’s instructions. Briefly, sections were re-hydrated,
washed in PBS and incubated at 37uC for 1 h with a TUNEL
reaction mixture. This allowed direct detection of fragmented
DNA in apoptotic cells with fluorescein-12-dUTP by means of the
enzyme TdT. Mock-infected sections were tested in parallel.
Apoptotic nuclei were visualized by confocal microscopy using a
Nikon Eclipse Te 2000-S microscope. In addition, apoptotic cells
were also detected by immunohistochemistry using a commercially
available kit (ApopTag Peroxidase In Situ Apoptosis Detection
Kit, Chemicon International) as described by the manufacturer.
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